Cargando…

The association of plasma cystatin C proteoforms with diabetic chronic kidney disease

BACKGROUND: Cystatin C (CysC) is an endogenous cysteine protease inhibitor that can be used to assess the progression of kidney function. Recent studies demonstrate that CysC is a more specific indicator of glomerular filtration rate (GFR) than creatinine. CysC in plasma exists in multiple proteofor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yassine, Hussein N., Trenchevska, Olgica, Dong, Zhiwei, Bashawri, Yara, Koska, Juraj, Reaven, Peter D., Nelson, Randall W., Nedelkov, Dobrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807542/ https://www.ncbi.nlm.nih.gov/pubmed/27019641 http://dx.doi.org/10.1186/s12953-016-0096-7

Ejemplares similares

The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
por: Yassine, Hussein N., et al.
Publicado: (2015)

Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms
por: Trenchevska, Olgica, et al.
Publicado: (2016)

Serum Amyloid A Truncations in Type 2 Diabetes Mellitus
por: Yassine, Hussein N., et al.
Publicado: (2015)

Delineation of Concentration Ranges and Longitudinal Changes of Human Plasma Protein Variants
por: Trenchevska, Olgica, et al.
Publicado: (2014)

Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
por: Koska, Juraj, et al.
Publicado: (2022)

Targeted quantitative mass spectrometric immunoassay for human protein variants
por: Trenchevska, Olgica, et al.
Publicado: (2011)

Cystatin C proteoforms in chronic kidney disease
por: Dahl, Helene, et al.
Publicado: (2023)

Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes
por: Nedelkov, Dobrin
Publicado: (2017)

Quantitative Mass Spectrometry Evaluation of Human Retinol Binding Protein 4 and Related Variants
por: Kiernan, Urban A., et al.
Publicado: (2011)

Mass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF)
por: Sherma, Nisha D, et al.
Publicado: (2014)

Parallel Workflow for High-Throughput (>1,000 Samples/Day) Quantitative Analysis of Human Insulin-Like Growth Factor 1 Using Mass Spectrometric Immunoassay
por: Oran, Paul E., et al.
Publicado: (2014)

Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid
por: Hu, Yueming, et al.
Publicado: (2020)

Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease
por: Hu, Yueming, et al.
Publicado: (2020)

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
por: Ansar, Sameer, et al.
Publicado: (2011)

Elucidating Proteoform Families from Proteoform Intact-Mass and Lysine-Count Measurements
por: Shortreed, Michael R., et al.
Publicado: (2016)

The Human Proteoform Atlas: a FAIR community resource for experimentally derived proteoforms
por: Hollas, Michael A R, et al.
Publicado: (2021)

The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT)
por: Koska, Juraj, et al.
Publicado: (2013)

Correction to “Elucidating Proteoform Families from Proteoform Intact-Mass and Lysine-Count Measurements”
por: Shortreed, Michael R., et al.
Publicado: (2017)

Proteomes Are of Proteoforms: Embracing the Complexity
por: Carbonara, Katrina, et al.
Publicado: (2021)

PROTEOFORMER 2.0: Further Developments in the Ribosome Profiling-assisted Proteogenomic Hunt for New Proteoforms
por: Verbruggen, Steven, et al.
Publicado: (2019)

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
por: Wildburger, Norelle C., et al.
Publicado: (2017)

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)
por: Koska, Juraj, et al.
Publicado: (2021)

Proteoforms and their expanding role in laboratory medicine
por: Forgrave, Lauren M., et al.
Publicado: (2021)

Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
por: Wong, Chee Wai, et al.
Publicado: (2015)

Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2010)

Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats
por: Ghys, L.F.E., et al.
Publicado: (2016)

Proteoform-Specific Insights into Cellular Proteome Regulation
por: Norris, Emma L., et al.
Publicado: (2016)

Deducing the presence of proteins and proteoforms in quantitative proteomics
por: Bamberger, Casimir, et al.
Publicado: (2018)

Pseudotrypsin: A Little-Known Trypsin Proteoform
por: Perutka, Zdeněk, et al.
Publicado: (2018)

Neurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges
por: Noor, Aneeqa, et al.
Publicado: (2021)

The Human Proteoform Project: Defining the human proteome
por: Smith, Lloyd M., et al.
Publicado: (2021)

Mapping the Proteoform Landscape of Five Human Tissues
por: Drown, Bryon S., et al.
Publicado: (2022)

Evaluation of Haptoglobin and Its Proteoforms as Glioblastoma Markers
por: Naryzhny, Stanislav, et al.
Publicado: (2021)

Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
por: Williams, T.L., et al.
Publicado: (2016)

Corticosteroids significantly increase cystatin C levels in the plasma by promoting cystatin C production in rats
por: Zhu, Xiao-Ran, et al.
Publicado: (2019)

Comprehensive Proteoform Characterization of Plasma Complement Component C8αβγ by Hybrid Mass Spectrometry Approaches
por: Franc, Vojtech, et al.
Publicado: (2018)

Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease
por: Lees, Jennifer S., et al.
Publicado: (2022)

Development of a Quantitative Immunoassay for Tear Lacritin Proteoforms
por: Justis, Brooke M., et al.
Publicado: (2020)

Molecular probes for cellular imaging of post-translational proteoforms
por: Suraritdechachai, Surased, et al.
Publicado: (2022)

Proteoform‐Selective Imaging of Tissues Using Mass Spectrometry
por: Yang, Manxi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1paguincsdjge123msm5vfrllt